Medtronic PSR TDD PMCF

Inclusion Criteria

• •Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
• •Patient has or is intended to receive or be treated with an eligible Medtronic product
• •Patient within enrollment window relative to therapy initiation or meets criteria for retrospective enrollment
• •The indication for implant meets approved indications
• •The patient can reasonably be expected to remain fully on label for a 48-month time period after implant